Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

Clinical trial NCT04277702 · UNKNOWN

Trial details

NCT number: NCT04277702
Sponsor: Jagiellonian University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease Peripheral Vascular Diseases Lower Limb Ischemia Atherosclerosis of Artery

Start date: 2020-05-01
Primary completion: 2023-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.